New U.S. USPSTF Guidelines for Colorectal Cancer Screening
First written in FY2017-Q1. 3 of 4 entries say "Restated". Latest entry: FY2017.
No other company in this theme has enough history to compare yet.
- FY2017RestatedAnnual report
「Following the issuance of new US guidelines for colorectal cancer screening in June 2016, we focused on expanding the adoption of fecal occult blood testing reagents and instruments.」
Activities to expand the adoption of fecal occult blood testing reagents and instruments based on the issuance of the new US guidelines continue. - FY2017-Q3RestatedAnnual report
「Following the issuance of new US guidelines for colorectal cancer screening in June 2016, we focused on expanding the adoption of fecal occult blood testing reagents and instruments.」
Activities to expand the adoption of fecal occult blood testing reagents and instruments based on the new US guidelines continue. - FY2017-Q2RestatedAnnual report
「Following the issuance of new US guidelines for colorectal cancer screening in June 2016, we focused on expanding the adoption of fecal occult blood testing reagents and instruments.」
The new US guidelines continue to be used as the basis for sales activities. - FY2017-Q1First statedAnnual report
「In June 2016, the US Preventive Services Task Force (USPSTF) issued new guidelines for colorectal cancer screening. We believe these guidelines will provide a tailwind for our sales activities in the United States going forward.」
The issuance of the new US guidelines is presented as an external factor creating a favorable environment for future sales activities.